PL2001445T3 - Farmaceutyczne sferoidy - Google Patents

Farmaceutyczne sferoidy

Info

Publication number
PL2001445T3
PL2001445T3 PL07733554T PL07733554T PL2001445T3 PL 2001445 T3 PL2001445 T3 PL 2001445T3 PL 07733554 T PL07733554 T PL 07733554T PL 07733554 T PL07733554 T PL 07733554T PL 2001445 T3 PL2001445 T3 PL 2001445T3
Authority
PL
Poland
Prior art keywords
spheroids
pharmaceutical
pharmaceutical spheroids
Prior art date
Application number
PL07733554T
Other languages
English (en)
Inventor
Helen Kathleen Danagher
Geoffrey Gerard Hayes
Hassan Mohammad
Malcolm Walden
Jonathon Oliver Whitehouse
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0605271A external-priority patent/GB0605271D0/en
Priority claimed from GB0605542A external-priority patent/GB0605542D0/en
Priority claimed from GB0617272A external-priority patent/GB0617272D0/en
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of PL2001445T3 publication Critical patent/PL2001445T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07733554T 2006-03-16 2007-03-16 Farmaceutyczne sferoidy PL2001445T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0605271A GB0605271D0 (en) 2006-03-16 2006-03-16 Pharmaceutical spheroids
GB0605542A GB0605542D0 (en) 2006-03-20 2006-03-20 Pharmaceutical Spheroids
GB0617272A GB0617272D0 (en) 2006-09-04 2006-09-04 Pharmaceutical spheroids
EP07733554.5A EP2001445B1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids
PCT/GB2007/050129 WO2007105016A1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids

Publications (1)

Publication Number Publication Date
PL2001445T3 true PL2001445T3 (pl) 2015-06-30

Family

ID=38191129

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07733554T PL2001445T3 (pl) 2006-03-16 2007-03-16 Farmaceutyczne sferoidy

Country Status (13)

Country Link
US (1) US9034373B2 (pl)
EP (1) EP2001445B1 (pl)
JP (2) JP5443768B2 (pl)
CY (1) CY1115770T1 (pl)
DK (1) DK2001445T3 (pl)
ES (1) ES2516693T3 (pl)
HR (1) HRP20141001T1 (pl)
ME (1) ME02135B (pl)
PL (1) PL2001445T3 (pl)
PT (1) PT2001445E (pl)
RS (1) RS53624B1 (pl)
SI (1) SI2001445T1 (pl)
WO (1) WO2007105016A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2001445T3 (da) * 2006-03-16 2014-10-27 Euro Celtique Farmaceutiske sfæroider
AT511581A1 (de) 2011-05-26 2012-12-15 G L Pharma Gmbh Orale retardierende formulierung
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol
CA3166250A1 (en) 2020-02-05 2021-08-12 Gregory G. Plucinski Drug products for intranasal administration and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471784A1 (fr) 1979-12-21 1981-06-26 Roussel Uclaf Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
EP0654263B1 (en) * 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
DE4415921A1 (de) * 1994-05-05 1995-11-09 Bayerische Motoren Werke Ag Vorrichtung zum Dämpfen von Schwingungen in einer Getriebeschaltvorrichtung für Fahrzeuge
CA2191562A1 (en) 1994-06-03 1995-12-14 Michelle Elizabeth Brideau Fast dissolving dosage forms
US5458823A (en) * 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
TW406022B (en) * 1994-12-19 2000-09-21 Daiichi Seiyaku Co Method for producing slow-release granular agents
CA2219991C (en) * 1995-05-02 2007-10-30 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition for oral administration
JP5042447B2 (ja) * 1995-07-21 2012-10-03 第一三共株式会社 混合製剤
KR100417746B1 (ko) 1995-07-21 2004-05-31 다이이찌 세이야꾸 가부시기가이샤 입상제제의제조방법
US5851454A (en) * 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6117452A (en) 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
HK1044476B (zh) * 1999-03-17 2010-09-17 第一制药株式会社 药物组合物
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
EP1368006B1 (en) 2001-02-13 2006-05-03 AstraZeneca AB Novel modified released formulation
CN100500130C (zh) * 2003-01-23 2009-06-17 株式会社太平洋 缓释制剂及其制备方法
EP1624859A4 (en) 2003-05-06 2010-06-23 Bpsi Holdings Inc METHOD FOR PRODUCING THERMOFORMED COMPOSITIONS WITH ACRYLIC POLYMER BINDERS, PHARMACEUTICAL DOSAGE FORMS, AND METHOD FOR THE PRODUCTION THEREOF
DK2001445T3 (da) * 2006-03-16 2014-10-27 Euro Celtique Farmaceutiske sfæroider

Also Published As

Publication number Publication date
JP5443768B2 (ja) 2014-03-19
ES2516693T3 (es) 2014-10-31
JP2014088363A (ja) 2014-05-15
WO2007105016A1 (en) 2007-09-20
DK2001445T3 (da) 2014-10-27
EP2001445B1 (en) 2014-07-23
JP2009530258A (ja) 2009-08-27
SI2001445T1 (sl) 2015-02-27
RS53624B1 (sr) 2015-04-30
US9034373B2 (en) 2015-05-19
PT2001445E (pt) 2014-10-24
EP2001445A1 (en) 2008-12-17
US20100047337A1 (en) 2010-02-25
HRP20141001T1 (hr) 2014-12-05
ME02135B (me) 2015-04-30
CY1115770T1 (el) 2017-01-25

Similar Documents

Publication Publication Date Title
IL194762A0 (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
ZA200806318B (en) Drug combinations
GB0614586D0 (en) Pharmaceutical Formulation
IL197883A0 (en) Combination drug
SI2001445T1 (sl) Farmacevtski sferoidi
GB0625783D0 (en) Medicament
GB0608176D0 (en) Pharmaceutical Compounds
GB0600528D0 (en) Drug detector
GB0608184D0 (en) Pharmaceutical compounds
GB0615064D0 (en) Medicament
GB0717882D0 (en) Novel pharmaceutical
GB0608175D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608996D0 (en) Drug counter
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
GB0605542D0 (en) Pharmaceutical Spheroids
GB0605271D0 (en) Pharmaceutical spheroids
GB0617272D0 (en) Pharmaceutical spheroids
GB0622892D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0618135D0 (en) Novel pharmaceutical
GB0614457D0 (en) Pharmaceutical Combinations